Cost-effectiveness of integrated disease management for high risk, exacerbation prone, patients with chronic obstructive pulmonary disease in a primary care setting

BACKGROUND: We evaluate the cost-effectiveness of the ‘Best Care’ integrated disease management (IDM) program for high risk, exacerbation prone, patients with chronic obstructive pulmonary disease (COPD) compared to usual care (UC) within a primary care setting from the perspective of a publicly fun...

Descripción completa

Detalles Bibliográficos
Autores principales: Scarffe, Andrew D., Licskai, Christopher J., Ferrone, Madonna, Brand, Kevin, Thavorn, Kednapa, Coyle, Doug
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373353/
https://www.ncbi.nlm.nih.gov/pubmed/35962399
http://dx.doi.org/10.1186/s12962-022-00377-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373353/
https://www.ncbi.nlm.nih.gov/pubmed/35962399
http://dx.doi.org/10.1186/s12962-022-00377-w

Ejemplares similares